📢 Gate Square #Creator Campaign Phase 2# is officially live!
Join the ZKWASM event series, share your insights, and win a share of 4,000 $ZKWASM!
As a pioneer in zk-based public chains, ZKWASM is now being prominently promoted on the Gate platform!
Three major campaigns are launching simultaneously: Launchpool subscription, CandyDrop airdrop, and Alpha exclusive trading — don’t miss out!
🎨 Campaign 1: Post on Gate Square and win content rewards
📅 Time: July 25, 22:00 – July 29, 22:00 (UTC+8)
📌 How to participate:
Post original content (at least 100 words) on Gate Square related to
Recently, Nasdaq-listed company Welgistics Health announced an intriguing strategic decision: to incorporate Ripple (XRP) into its business model. This move not only views XRP as an investment vehicle but also plans to use it as a means of payment and a source of profit, sparking widespread discussion in the Crypto Assets community.
The documents submitted by the company to the U.S. Securities and Exchange Commission (SEC) elaborate on this plan in detail. According to Ripple's legal advisor Bill Morgan, Welgistics Health intends to deeply integrate XRP into the company's financial and operational structure. The company hopes to optimize transaction processes with pharmacy clients, manufacturers, and distribution partners using the infrastructure of the XRP ledger, in order to achieve cost control and real-time processing.
Moreover, it is worth noting that Welgistics Health plans to raise funds through future stock or bond issuances to purchase more XRP. These digital assets will not only be used as collateral for financing, but the company also intends to generate revenue from XRP-based transactions. This initiative highlights the multiple potentials of XRP as an investment vehicle, payment medium, and collateral asset.
However, this strategy has also sparked controversy within the Crypto Assets community. While XRP supporters see it as a significant breakthrough in the application field, some industry experts have expressed concerns about Welgistics Health's financial situation. Former securities lawyer Mark Fagel pointed out that the company has limited actual assets and that its recent financial report included a 'going concern' warning, raising questions about the company's financial stability.
In addition, there are views that Welgistics Health may use XRP as a marketing tool to attract the attention of investors. Whether this approach can bring substantial commercial value to the company remains to be seen.
Overall, Welgistics Health's decision to incorporate XRP into its business model reflects the further integration of traditional finance and the world of Crypto Assets. This move not only showcases the potential applications of XRP in corporate payments and financial operations but also sparks deeper reflection on the company's strategy and the role of Crypto Assets in the business environment. As the situation develops, the market will closely monitor the implementation effects of this innovative model and its impact on the Crypto Assets industry.